Hye Na Kim

Employment

• Stanford University

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (31)

• Mesenchymal stem cells in ribosomal insufficiency lead to aberrant osteoblastic differentiation and altered hematopoiesis.
  Haematologica 2026 DOI: 10.3324/haematol.2026.301254
  +Save
• Integrin Alpha 4 Inhibition Prolongs the Survival of NSG Mice Engrafted with CD19-Negative Post-CART19 Relapsed B-ALL
  Experimental Hematology 2026 DOI: 10.1016/j.exphem.2026.105471
  +Save
• Aberrant cell cycle regulation and osteoblastic differentiation in diamond-blackfan anemia (DBA) mesenchymal stem cells
  Hye Na Kim, Jacob Viduya, Jenny Youm +9 more
  2025 DOI: 10.1182/blood-2025-747
  +Save
• Inflammatory Pathways and the Bone Marrow Microenvironment in Inherited Bone Marrow Failure Syndromes.
  Nicholas Neoman, Hye Na Kim, Jacob Viduya +3 more
  Stem cells (Dayton, Ohio) 2025 DOI: 10.1093/stmcls/sxaf021
  +Save
• Activation of nemo-like kinase in diamond blackfan anemia suppresses early erythropoiesis by preventing mitochondrial biogenesis
  Mark C. Wilkes, Aya Shibuya, Y. Lucy Liu

  +8 more

  • Kailen Mark
  • Jaqueline Mercado
  • Mallika Saxena
  • Ryan S. Sathianathen
  • Hye Na Kim
  • +3 more
  Journal of Biological Chemistry 2024 DOI: 10.1016/j.jbc.2024.107542
  +Save
• Altered physical phenotypes of leukemia cells that survive chemotherapy treatment
  INTEGRATIVE BIOLOGY 2023 DOI: 10.1093/intbio/zyad006
  +Save
• The Role of Integrin Beta-1 in the Chemoresistance of Acute Myeloid Leukemia
  Blood 2022 DOI: 10.1182/blood-2022-167902
  +Save
• In vitro and in vivo effects of AVA4746, a novel competitive antagonist of the ligand binding of VLA-4, in B-cell acute lymphoblastic leukemia
  EXPERIMENTAL AND THERAPEUTIC MEDICINE 2022 DOI: 10.3892/etm.2021.10969
  +Save
• PI3K Targeting in Non-solid Cancer
  PI3K AND AKT ISOFORMS IN IMMUNITY 2022 DOI: 10.1007/978-3-031-06566-8_17
  +Save
• Preclinical Evaluation of a Novel Dual Targeting PI3Kδ/BRD4 Inhibitor, SF2535, in B-Cell Acute Lymphoblastic Leukemia
  FRONTIERS IN ONCOLOGY 2021 DOI: 10.3389/fonc.2021.766888
  +Save
• Potentially Curative Therapeutic Activity of NEO212, a Perillyl Alcohol-Temozolomide Conjugate, in Preclinical Cytarabine-Resistant Models of Acute Myeloid Leukemia
  CANCERS 2021 DOI: 10.3390/cancers13143385
  +Save
• Wnt Signaling in the Tumor Microenvironment
  TUMOR MICROENVIRONMENT: SIGNALING PATHWAYS, PT B 2021 DOI: 10.1007/978-3-030-47189-7_7
  +Save
• Cadherins, Selectins, and Integrins in CAM-DR in Leukemia
  FRONTIERS IN ONCOLOGY 2020 DOI: 10.3389/fonc.2020.592733
  +Save
• Wnt Signaling in Leukemia and Its Bone Marrow Microenvironment
  INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2020 DOI: 10.3390/ijms21176247
  +Save
• Integrin α6 mediates the drug resistance of acute lymphoblastic B-cell leukemia
  BLOOD 2020 DOI: 10.1182/blood.2019001417
  +Save
• Characterizing the Motility of Chemotherapeutics-Treated Acute Lymphoblastic Leukemia Cells by Time-Lapse Imaging
  CELLS 2020 DOI: 10.3390/cells9061470
  +Save
• CAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression
  LEUKEMIA 2020 DOI: 10.1038/s41375-020-0792-2
  +Save
• Minimal Residual Disease Detection in Acute Lymphoblastic Leukemia
  INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2020 DOI: 10.3390/ijms21031054
  +Save
• Cell Adhesion of ALL to Stromal Cells May Mediate CAR T-Cell Resistance: A Novel Escape Mechanism for Immunotherapy
  Blood 2019 DOI: 10.1182/blood-2019-132131
  +Save
• Targeting of Integrin α4/VCAM-1 with AVA4746 Modulates the Redox-Status and Metabolism in ALL and Angiogenesis
  Blood 2019 DOI: 10.1182/blood-2019-132101
  +Save